Patents by Inventor Fumi Nagatsugi

Fumi Nagatsugi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240018583
    Abstract: The present disclosure provides a technique for efficiently detecting a wider variety of RNA higher-order structures including non-Watson-Crick base pair-type higher order structures. The method for analyzing the RNA higher-order structure according to the present disclosure comprises the steps of providing a compound in which a target-binding moiety Sm and an RNA-modifying moiety Y are linked by a linker L; contacting the compound and one or a plurality of RNAs; determining a nucleotide sequence of the RNA after contacting with the compound; and determining a position and/or a region on the RNA that interacts with the target binding moiety of the compound, based on the nucleotide sequence.
    Type: Application
    Filed: September 28, 2023
    Publication date: January 18, 2024
    Inventors: Kaoru Richard KOMATSU, Emi MIYASHITA, Kazumitsu ONIZUKA, Fumi NAGATSUGI
  • Patent number: 7642343
    Abstract: The invention provides a conjugate of functional oligonucleotide with poly(ethylene oxide), polyion complex of the conjugate with cationic polymer, and micelle thereof. The micelle improves stability of the oligonucleotide in animal cells and its specific bindability to target gene.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: January 5, 2010
    Assignee: Japan Science and Technology Agency
    Inventors: Yukio Nagasaki, Kazunori Kataoka, Shigeki Sasaki, Fumi Nagatsugi, Motoi Oishi
  • Publication number: 20080097087
    Abstract: The invention provides a conjugate of functional oligonucleotide with poly(ethylene oxide), polyion complex of the conjugate with cationic polymer, and micelle thereof. The micelle improves stability of the oligonucleotide in animal cells and its specific bindability to target gene.
    Type: Application
    Filed: April 14, 2005
    Publication date: April 24, 2008
    Inventors: Yukio Nagasaki, Kazunori Kataoka, Shigeki Sasaki, Fumi Nagatsugi, Motoi Oishi
  • Patent number: 6900307
    Abstract: There are provided 2-aminopurine derivatives represented by the following general formula (1): where R represents any species selected from the group consisting of hydrogen and acyl groups, X represents any species selected from the group consisting of phosphoramidite and oligonucleotides, Y represents any species selected from the group consisting of dimethyltrityl groups and oligonucleotides, and Z1, Z2, Z3, Z4 and Z5 are the same or different and represent any species selected from the group consisting of hydrogen and hydroxyl, amino, lower alkyl, alkoxy, carboxyl and sulfonic acid groups, provided that Z1, Z2, Z3, Z4 and Z5 are not all hydrogen, as well as gene expression-regulating compositions characterized by comprising the derivatives. By introducing the 2-aminopurine derivatives into oligonucleotides it is possible to achieve crosslinking reaction with high reactivity for target nucleic acids and notably high base sequence specificity.
    Type: Grant
    Filed: November 2, 2000
    Date of Patent: May 31, 2005
    Assignee: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Shigeki Sasaki, Fumi Nagatsugi, Minoru Maeda